Genetic Testing May Benefit Older Women with Breast Cancer
About 1 in 40 postmenopausal women diagnosed with breast cancer before age 65 have cancer-associated mutations in their BRCA1 or BRCA2 genes, according to a Stanford-led study of more than 4,500 participants in the long-running Women’s Health Initiative. The prevalence of the mutations in this group is similar to that of Ashkenazi Jewish women, whom […]
Read More